
Hims Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: people who want brand-name GLP-1 pills or pens through a big-name app with 24/7 messaging
Hims scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Price checked on Hims’s site,
What the monthly price covers
Medication
Included
Provider visits
Billed separately
Shipping
Not stated
Lab work
Not stated
Coaching
Billed separately
No insurance needed · Vetted by our editors
Hims, the men's brand of publicly traded Hims & Hers Health, now offers brand-name GLP-1s only: Wegovy pill and pen, Ozempic, Zepbound and the new Foundayo pill. Medication starts at $149/mo for the pills and $199/mo for pens, billed monthly, and every plan also requires the Hims Weight Loss Membership at $39 for the first month, then $149/mo.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Hims
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Hims at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy Pill, Zepbound
- Starting price
- $149/mo (+ required membership)
- What's included
- Medication
- FDA status
- 1 FDA warning letter on record; see below
How we scored Hims
Each dimension is scored algorithmically from Hims’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.9/10Hims' brand-name medication starts at $149/mo, with a required membership or program fee billed on top. Its value score is measured against the $179 median for GLP-1 providers, which compounded programs set, so brand-name sellers score lower on value by design.
Effectiveness25%
8.2/10Hims offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. It prescribes FDA-approved brand-name medication rather than compounded versions.
User Experience15%
7.4/10Online intake and platform experience (ongoing clinician messaging); 6 platform features disclosed.
Trust & Safety15%
5.6/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above); discloses its pharmacy partners.
Accessibility10%
5.9/10Hims's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.8/10Coaching not included in the base price, clinician messaging between visits.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Hims review
Last checked October 2026- Confirmed current pricing across 6 dose/plan tiers and 1 separate fee
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$1,899/mo across 6 dose/plan tiers, plus a $149/mo fee that excludes the medication (checked October 2026)
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with Hims
We walked Hims’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the weight-loss page, which lists each GLP-1 (Wegovy pill and pen, Ozempic, Zepbound, Foundayo, Mounjaro) with a starting monthly medication price.
- 2Click 'See if I'm eligible' to open the online intake.
- 3The first intake screen asks for your weight-loss goal (1-15 lbs, 16-50 lbs, 51+ lbs, or not sure).
- Every medication price is marked 'medication only'; the required membership ($39 first month, then $149/mo) is billed separately and 'does not include or guarantee a prescription.'
- Brand-name GLP-1s only; no compounded options are offered.
- Product pages say the pill and pen prices are 'billed monthly' and that pricing may vary by dosage.
- The FAQ says a video visit may not be needed depending on your state.
- The FAQ says GLP-1s are not yet available in all 50 states, but no state list is published.
- Membership perks include 24/7 provider messaging, a Care Team, in-app tracking and an opt-in smart scale.
Hims customer support
- Phone
- 1-800-368-0038
- support@forhims.com
GLP-1 medications Hims offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$39 first month, then auto-renews at $149/mo. Required for any GLP-1 prescription and billed separately from medication; does not guarantee a prescription.
Medication only; plus the required $149/mo membership. A Wegovy pill microdosing plan is also listed from $149/mo. Pricing may vary by dose.
Medication only; plus the required membership. Ozempic is FDA-approved for type 2 diabetes; eligibility set by the provider.
Medication only; plus the required $149/mo membership. Ozempic pen also listed from $199/mo.
Medication only; plus the required $149/mo membership.
Medication only; plus the required $149/mo membership. Pricing may vary by dose.
Listed at $1,899/mo medication only, plus the required membership. Mounjaro is FDA-approved for type 2 diabetes.
Ready to get started?
Plans and promotions change often, so check Hims's current pricing and active discounts before you decide.
What we like
- FDA-approved brand-name GLP-1s only, including the Wegovy pill, Wegovy pen, Zepbound and Foundayo
- Starting medication prices are published before you start the intake
- Oral options (Wegovy pill, Ozempic pill, Foundayo) start at $149/mo for medication
- Membership includes 24/7 messaging with licensed providers and a dedicated Care Team
- Generic Zofran for nausea is included at no extra cost if prescribed
- Cancel the membership or medication plan anytime in the app or by phone
Watch-outs
- A Weight Loss Membership ($39 first month, then $149/mo) is required on top of medication, so the pill costs about $298/mo in total
- No compounded semaglutide or tirzepatide, so there is no lower-cost option
- The first month's membership fee is non-refundable and medication can't be refunded once shipped
- GLP-1s are not available in all 50 states and Hims does not publish which states are covered
- Prices shown are starting prices and may change with your dose
- Canceling the membership also cancels your medication plan and access to care
Hims: a mainstream brand makes GLP-1s feel ordinary
Hims is one of the few telehealth names a lot of people already recognize before they ever think about weight loss, and that familiarity is the whole pitch here. Most GLP-1 providers are small, single-purpose startups you have to vet from scratch. Hims is a publicly traded company (part of Hims & Hers) that has spent years building a polished, app-first intake most patients can navigate without help. For the right person, that ordinariness is the appeal: it's brand-name semaglutide and tirzepatide access that doesn't feel like you're trusting your prescription to a brand-new pop-up. The trade-off is that 'mainstream' comes with a stacked bill, so you have to know what you're signing up for.
What you pay, and the part that's easy to miss
Hims lists its cheapest medication, the Wegovy pill, at $149 a month (+ required membership), billed monthly. The Ozempic pill and the new Foundayo (orforglipron) pill start at the same $149, the Wegovy and Ozempic pens start at $199, and Zepbound vials and KwikPens start at $299. Those are starting prices, and Hims says pricing may vary by dose. On the medication line alone, that compares well with the category median of $179.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
But the medication price is not the whole bill. Every price Hims shows is marked 'medication only.' A separate Weight Loss Membership is required for any prescription: $39 for the first month, then it auto-renews at $149 a month. So the cheapest pill plan costs roughly double the headline once the membership is added, and the membership 'does not include or guarantee a prescription.' If you only compare the per-month drug price to other providers, you'll undercount what Hims costs. PrideRx uses a similar membership-plus-medication setup, but its prescriptions are billed and shipped by LillyDirect or NovoCare.
The medication menu: brand-name only
Hims no longer lists compounded semaglutide on its weight-loss pages. The menu is now FDA-approved, brand-name GLP-1s only:
- Wegovy pill (oral semaglutide), including a microdosing plan, from $149/mo
- Ozempic pill and Foundayo pill (oral orforglipron), from $149/mo
- Wegovy pen and Ozempic pen (weekly injections), from $199/mo
- Zepbound vial or KwikPen (tirzepatide), from $299/mo
- Mounjaro or Zepbound pens at full list price, for patients who want that route
That is a big shift. Brand-name means sealed, commercially manufactured products rather than pharmacy-prepared versions, which some patients specifically want. It also means there is no lower-cost compounded option at Hims anymore. Ozempic and Mounjaro are FDA-approved for type 2 diabetes, so the prescriber decides if you're eligible for those.
What sets Hims apart
Two things stand out. First is breadth: few telehealth programs carry three oral options (Wegovy pill, Ozempic pill, Foundayo) next to the pens and Zepbound, with starting prices posted before you begin the intake. Second is the integrated experience. Intake, prescription, refills, and support all live inside one familiar app, and the membership includes 24/7 messaging with licensed providers and a dedicated Care Team. Generic Zofran for nausea is included at no extra cost if it's prescribed. Everything sits in one account, so you're not stitching together a clinic, a pharmacy, and a coaching app.
One caveat on reach: Hims & Hers says the brand as a whole is available in all 50 states, but its own FAQ says GLP-1s are not yet available in all 50 states, and it doesn't publish which states are covered. Depending on your state, treatment may be decided without a video visit. Check that your state is covered for the weight-loss program during intake.
Who should choose Hims, and who should skip it
Hims fits you if you want a brand-name GLP-1, especially a pill, from a recognizable, low-friction company, and you value a smooth app and round-the-clock messaging over rock-bottom pricing. It's a sensible default for someone who wants mainstream brand-name access without researching a dozen unknown startups.
Skip it if you're cost-optimizing to the dollar. Once the membership is added, the all-in cost of even the cheapest pill is well above what many compounded providers charge. Skip it, too, if you want compounded semaglutide or tirzepatide specifically, because Hims doesn't offer it. Our semaglutide for men page ranks prescribers that do, next to the testosterone and muscle-preservation questions men usually bring to a first visit. In Colorado, Eclipse Medical Wellness takes a different brand-name route, with lab monitoring and a prior-authorization attempt built into its care plan.
Cancellation, refunds, and oversight
You can cancel the membership or the medication plan anytime in the app or by phone, but read the fine print. The first month's membership fee is non-refundable. A medication plan is refunded only if you cancel within 48 hours of your first order or at least 2 days before a renewal, and nothing is refunded once medication ships. Canceling the membership also cancels any active medication plan and your access to care.
On safety fundamentals, prescriptions require a clinical evaluation, and as a public company Hims & Hers operates under more scrutiny than a typical private startup. That's a meaningful trust signal, but Hims does have an FDA warning letter on file, covered in the regulatory notice below. You can see how we weigh these factors in our scoring methodology. Confirm the current medication price for your dose, the membership cost, and your state's eligibility directly at intake.
Bottom line
Hims is the safe, mainstream brand-name choice: Wegovy, Ozempic, Foundayo and Zepbound from a well-funded company, with medication starting at $149 a month (+ required membership) and an easy app. Just go in clear-eyed. The required membership is a separate, stacked cost, there is no compounded option, and the GLP-1 program isn't offered in every state. If you value brand-name medication and a frictionless experience over the lowest possible price, Hims earns its place on the shortlist. If you're price-hunting, a compounded provider will usually cost less.
The Bottom Line
Hims scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with Hims?
From $149/mo (+ required membership). See current pricing and start your free consultation.
Hims might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Hims vs…
Hims scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.

Hims vs Found
Found scores 8.3/10
Hims vs Enhance MD
Enhance MD scores 8.2/10

Hims vs Sesame Care
Sesame Care scores 8.0/10
Hims vs Amazon One Medical
Amazon One Medical scores 8.5/10

Hims vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Hims received an FDA warning letter dated September 9, 2025
The letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Hims review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Hims's current pricing
Plans from $149/mo (+ required membership). Start your free consultation to check eligibility and today's price.